Novel rapid treatment options for adolescent depression.
Pharmacological Research March 1, 2024 Sandra Ledesma-Corvi, Jordi Jornet-Plaza, Laura Gálvez-melero et al. 22 citations
There is an urgent need for novel fast-acting antidepressants for adolescent treatment-resistant depression and/or suicidal risk, since the selective serotonin reuptake inhibitors that are clinically approved for that age (i.e., fluoxetine or escitalopram) take weeks to work. In this context, one of the main research lines of our group is to characterize at the preclinical level novel...